🇺🇸 FDA
Patent

US 11975029

Compositions and methods for inhibition of lineage specific proteins

granted A61KA61K2239/38A61K2239/48

Quick answer

US patent 11975029 (Compositions and methods for inhibition of lineage specific proteins) held by Vor Biopharma Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vor Biopharma Inc.
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2239/38, A61K2239/48, A61K35/17, A61K35/28